ImportRefusal LogoImportRefusal

Natuzen Co., Ltd.

⚠️ Moderate Risk

FEI: 3006731547 • Namdong District, Incheon • SOUTH KOREA

FEI

FEI Number

3006731547

📍

Location

Namdong District, Incheon

🇰🇷
🏢

Address

(nonhyeonng) 47b-8l, Namdong Ind. Complex, 289, Namdongdong-ro, Namdong District, Incheon, South Korea

Moderate Risk

FDA Import Risk Assessment

39.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
6
Unique Violations
5/30/2024
Latest Refusal
4/21/2008
Earliest Refusal

Score Breakdown

Violation Severity
51.4×40%
Refusal Volume
25.9×30%
Recency
52.9×20%
Frequency
2.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4741×

COSMETLBLG

It appears the label does not bear the common or usual name of the cosmetic.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
5/30/2024
66PBJ99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
27DRUG GMPS
Division of Southeast Imports (DSEI)
5/18/2009
53ED01HAIR CONDITIONERS (HAIR PREPARATIONS, NON-COLORING)
471CSTIC LBLG
474COSMETLBLG
475COSMETLBLG
Baltimore District Office (BLT-DO)
4/30/2008
53LY01CLEANSING (COLD CREAMS, CLEANSING LOTIONS, LIQUIDS, PADS) (SKIN CARE PREPARATIONS)
471CSTIC LBLG
Seattle District Office (SEA-DO)
4/21/2008
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
472NO ENGLISH
75UNAPPROVED
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Natuzen Co., Ltd.'s FDA import refusal history?

Natuzen Co., Ltd. (FEI: 3006731547) has 4 FDA import refusal record(s) in our database, spanning from 4/21/2008 to 5/30/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Natuzen Co., Ltd.'s FEI number is 3006731547.

What types of violations has Natuzen Co., Ltd. received?

Natuzen Co., Ltd. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Natuzen Co., Ltd. come from?

All FDA import refusal data for Natuzen Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.